Ramucirumab Plus Paclitaxel As Switch Maintenance Versus Continuation of Oxaliplatin-Based Chemotherapy in Patients (pts) with Advanced HER2-negative Gastric or Gastroesophageal Junction (GEJ) Cancer: the ARMANI Phase III Trial.

G. Randon,F. Nappo,M. Fassan,S. Tamberi,E. Giommoni,S. Di Donato,L. Fornaro,O. Brunetti,F. De Vita,G. L. Frassineti,C. Chini,A. Spallanzani, V. Bethaz,A. Strippoli,T. P. Latiano,G. Cardellino,C. Ceccon,F. Palermo,M. Di Bartolomeo,F. Pietrantonio

ANNALS OF ONCOLOGY（2024）

引用 0|浏览11

关键词

613-135-2370-7650-2700,283-2627,283-424-6846-174,130-540-543-12277-2683,613-135-2370-2813-7645,283-2494,613-4678-146-1331,3620,239,3620,117,239,1700,1589,38115-38109-2576,38092-20072

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要